Skip to main content
. Author manuscript; available in PMC: 2014 Feb 2.
Published in final edited form as: Am Heart J. 2012 Oct 29;164(6):862–868. doi: 10.1016/j.ahj.2012.08.019

Figure 1.

Figure 1

Predicted net fluid loss at 72 hours, based on a multivariate model containing qualifying furosemide dose, mode of administration (bolus or continuous infusion), and an interaction term. Similar results (e.g., greater net fluid loss at lower qualifying doses with a bolus strategy) were obtained when stratified by intravenous dose intensity (data not shown).

HHS Vulnerability Disclosure